Clindamycin ABM

देश: न्यूज़ीलैंड

भाषा: अंग्रेज़ी

स्रोत: Medsafe (Medicines Safety Authority)

सक्रिय संघटक:

Clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin

थमां उपलब्ध:

Boucher & Muir (New Zealand) Limited t/a BNM Group

INN (इंटरनेशनल नाम):

Clindamycin hydrochloride 177.515 mg (equivalent to 150 mg clindamycin)

डोज़:

150 mg

फार्मास्यूटिकल फॉर्म:

Capsule

रचना:

Active: Clindamycin hydrochloride 177.515mg equivalent to 150 mg clindamycin Excipient: Erythrosine Gelatin Indigo carmine Lactose monohydrate Magnesium stearate Maize starch Opacode white S-1-18086 Purified talc Titanium dioxide

पैकेज में यूनिट:

Blister pack, white PVC/PE/PVdC-aluminium, 16 capsules

वर्ग:

Prescription

प्रिस्क्रिप्शन प्रकार:

Prescription

द्वारा बनाया गया:

Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd

चिकित्सीय संकेत:

Upper respiratory infections including tonsillitis, pharyngitis, sinusitis, otitis media and scarlet fever. Lower respiratory infections including bronchitis, pneumonia, empyema and lung abscess.

उत्पाद समीक्षा:

Package - Contents - Shelf Life: Blister pack, white PVC/PE/PVdC-aluminium - 16 capsules - 3 years from date of manufacture stored at or below 25°C - Blister pack, white PVC/PE/PVdC-aluminium - 24 capsules - 3 years from date of manufacture stored at or below 25°C

प्राधिकरण की तारीख:

2011-03-03

सूचना पत्रक

1
CLINDAMYCIN ABM
Consumer Medicine Information
CLINDAMYCIN ABM
_CLINDAMYCIN (AS HYDROCHLORIDE) _
Capsules 150 mg
WHAT IS IN THIS LEAFLET
Please read this leaflet carefully before you start taking Clindamycin
ABM.
This leaflet answers some common questions about Clindamycin ABM. It
does not
contain
all
the
available
information.
The
most
up-to-date
Consumer
Medicine
Information can be downloaded from www.medsafe.govt.nz.
Reading this leaflet does not take the place of talking to your doctor
or pharmacist.
All medicines have risks and benefits. Your doctor has weighed the
risks of you taking
Clindamycin ABM against the benefits this medicine is expected to have
for you.
IF
YOU
HAVE
ANY
CONCERNS
ABOUT
TAKING
THIS
MEDICINE,
ASK
YOUR
DOCTOR
OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may want to read it again.
WHAT CLINDAMYCIN ABM IS USED FOR
Clindamycin ABM contains clindamycin, an antibiotic. Clindamycin is
used to treat
bacterial infections in different parts of the body.
It works by killing or stopping the growth of the bacteria causing
your infection.
Clindamycin ABM will not work against viral infections such as colds
or flu.
Your doctor may have prescribed this medicine for another reason.
ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY IT HAS BEEN
PRESCRIBED FOR
YOU.
Clindamycin ABM is available only with a doctor's prescription.
Clindamycin ABM is not addictive.
2
CLINDAMYCIN ABM
BEFORE YOU TAKE CLINDAMYCIN ABM
Clindamycin ABM is not suitable for everyone.
_ _
_WHEN YOU MUST NOT TAKE IT _
DO NOT TAKE CLINDAMYCIN ABM IF YOU ARE ALLERGIC TO ANY MEDICINE
CONTAINING
CLINDAMYCIN, LINCOMYCIN (A SIMILAR ANTIBIOTIC), OR ANY OF THE
INGREDIENTS LISTED AT THE
END OF THIS LEAFLET.
DO NOT TAKE IT AFTER THE EXPIRY DATE (‘EXP. DATE’) PRINTED ON THE
PACK.
If you take it after the expiry date has passed, it may not work as
well.
DO NOT TAKE IT IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING.
IF YOU ARE NOT SURE WHETHER YOU SHOULD START TAKING THIS MEDICINE,
TALK TO YOUR
DOCTOR OR PHARMACIST.
_BEFORE

उत्पाद विशेषताएं

1
CLINDAMYCIN ABM
CLINDAMYCIN 150MG CAPSULES
NEW ZEALAND DATA SHEET
1
PRODUCT NAME
CLINDAMYCIN ABM 150 mg capsules
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Clindamycin ABM capsule contains clindamycin hydrochloride
equivalent to 150
mg of clindamycin.
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Clindamycin ABM capsules are hard gelatin capsules with a lavender
body and maroon
cap, imprinted with ‘CL 150’ in white.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Clindamycin hydrochloride has been shown to be effective in the
treatment of the
following infections when caused by susceptible anaerobic bacteria or
susceptible strains
of Gram-positive bacteria such as streptococci, staphylococci and
pneumococci:
1.
Upper respiratory infections including tonsillitis, pharyngitis,
sinusitis, otitis media
and scarlet fever.
2.
Lower respiratory infections including bronchitis, pneumonia, empyema
and lung
abscess.
3.
Skin
and
soft
tissue
infections
including
acne,
furuncles,
cellulitis,
impetigo,
abscesses, and wound infections. For specific skin and soft tissue
infections like
erysipelas and paronychia (panaritium), it would seem logical that
these conditions
would respond very well to clindamycin therapy.
4.
Bone and joint infections including osteomyelitis and septic
arthritis.
5.
Pelvic infections including endometritis, cellulitis, vaginal cuff
infection, tubo-
ovarian
abscesses,
salpingitis
and
pelvic
inflammatory
disease
when
given
in
conjunction with an antibiotic of appropriate Gram-negative aerobic
spectrum. In
cases of cervicitis due to
_Chlamydia trachomatis_
, mono therapy with clindamycin has
been shown to be effective in eradicating the organism.
6.
Intra-abdominal infections including peritonitis and abdominal abscess
when given
in conjunction with an antibiotic of appropriate Gram-negative aerobic
spectrum.
7.
Septicaemia and endocarditis - the effectiveness of clindamycin in the
treatment of
2
CLINDAMYCIN ABM
CLINDAMYCIN 150MG CAPSULES
selected cases of endocardit